Suminaga K, Nomizo T, Yoshida H, Ozasa H, et al. The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study. J Cancer Res Clin Oncol 2025;151:61.
PMID: 39903279